Monday, January 17, 2022
48.7 F
Fort Worth

UnitedHealth to acquire Diplomat

🕐 1 min read

UnitedHealth plans to acquire Diplomat Pharmacy at a steep discount about a month after the specialty drug provider said it may not be able to make its debt payments. United Health Group’s OptumRx subsidiary will pay $4 cash a share for Diplomat, a 31% discount to the stock’s closing price on Friday. Diplomat provides specialty drugs that treat cancer patients and others with complex medical conditions. Diplomat warned last month that it couldn’t renew a deal to stay in the specialty pharmacy and retail networks of a big payer it did not name.

It lost $177 million in the third quarter. Specialty drugs are big business for pharmacy benefit managers like OptumRx. Insurers and employers see these expensive drugs as a major factor behind rising health care costs, and they are focusing more on managing the cost of the drugs and where they are administered. Diplomat shares fell 32.7% and UnitedHealth shares fell 0.9% on Monday

Related Articles

Our Digital Sponsors

Latest Articles

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

This field is for validation purposes and should be left unchanged.